Skip to content
★ Sign in to follow
SC

Steven C. Jones

Executive
Total declarations
91
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (63 ops.)
€59.6M

Latest filing published 11 Jan 2021 for Neogenomics INC, €579k.

Filing timeline

BuySale
Steven C. Jones

Insider track record

Disclosed buys
0
Disclosed sells
63
Signal history

Steven C. Jones: trading record in brief

Steven C. Jones discloses dealings in Neogenomics Inc to SEC (Form 4). Between 6 June 2012 and 7 January 2021, the trades on record add up to 91 filings.

Sales make up the whole of the open-market record (63 sales, €59.6M). Other entries cover 6 share grants and 6 option exercises.

The latest filing, published on 11 January 2021, reports an option exercise of €579k in Neogenomics Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Steven C. Jones

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations90 total
  • ◇
    DirectorExecutivesNeogenomics Inc
    715,000 USD11SEC
    100,000 shares@ US$7.151.0% of flowCommon StockSEC:0001077183-21-000053:0
  • ◇
    DirectorExecutivesNeogenomics Inc
    72,700 USD11SEC
    10,000 shares@ US$7.270.1% of flowCommon StockSEC:0001077183-21-000053:1
  • ◇
    DirectorExecutivesNeogenomics Inc
    34,997 USD11SEC
    3,017 shares@ US$11.600.0% of flowCommon StockSEC:0001077183-21-000053:2
  • ◇
    DirectorExecutivesNeogenomics Inc
    96,138 USD11SEC
    4,269 shares@ US$22.520.1% of flowCommon StockSEC:0001077183-21-000053:3
  • ▼
    DirectorExecutivesNeogenomics Inc
    1M USD29SEC
    20,000 shares@ US$50.302.8% of flowCommon StockSEC:0001077183-20-000225:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    1M USD29SEC
    25,000 shares@ US$50.523.5% of flowCommon StockSEC:0001077183-20-000225:1
  • ▼
    DirectorExecutivesNeogenomics Inc
    1M USD29SEC
    25,000 shares@ US$51.673.6% of flowCommon StockSEC:0001077183-20-000225:2
  • ▼
    DirectorExecutivesNeogenomics Inc
    958,102 USD29SEC
    19,948 shares@ US$48.032.7% of flowCommon StockSEC:0001077183-20-000221:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    3M USD30SEC
    64,394 shares@ US$48.078.7% of flowCommon StockSEC:0001077183-20-000221:1
  • ▼
    DirectorExecutivesNeogenomics Inc
    2M USD30SEC
    45,658 shares@ US$49.456.3% of flowCommon StockSEC:0001077183-20-000221:2
  • ▼
    DirectorExecutivesNeogenomics Inc
    1M USD23SEC
    38,951 shares@ US$36.344.1% of flowCommon StockSEC:0001077183-20-000189:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    5M USD25SEC
    141,049 shares@ US$36.9515.1% of flowCommon StockSEC:0001077183-20-000189:1
  • ▼
    DirectorExecutivesNeogenomics Inc
    694,640 USD23SEC
    19,000 shares@ US$36.562.0% of flowCommon StockSEC:0001077183-20-000189:2
  • ▼
    DirectorExecutivesNeogenomics Inc
    3M USD24SEC
    81,000 shares@ US$36.558.6% of flowCommon StockSEC:0001077183-20-000189:3
  • ●
    DirectorExecutivesNeogenomics Inc
    0SEC
    25,000 shares0Common StockSEC:0001077183-20-000189:4
  • ▼
    DirectorExecutivesNeogenomics Inc
    376,691 USD11SEC
    10,426 shares@ US$36.131.1% of flowCommon StockSEC:0001077183-20-000185:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    3M USD12SEC
    71,583 shares@ US$36.987.6% of flowCommon StockSEC:0001077183-20-000185:1
  • ▼
    DirectorExecutivesNeogenomics Inc
    1M USD11SEC
    37,991 shares@ US$37.134.1% of flowCommon StockSEC:0001077183-20-000185:2
  • ◆
    DirectorExecutivesNeogenomics Inc
    0SEC
    2,698 shares0Common StockSEC:0001077183-20-000129:0
  • ◇
    DirectorExecutivesNeogenomics Inc
    597,500 USD11SEC
    125,000 shares@ US$4.781.6% of flowCommon StockSEC:0001077183-20-000049:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    7M USD13SEC
    250,000 shares@ US$28.8516.8% of flowCommon StockSEC:0001077183-20-000045:0
  • ▼
    DirectorExecutivesNeogenomics Inc
    712,000 USD11SEC
    25,000 shares@ US$28.481.7% of flowCommon StockSEC:0001077183-20-000045:1
  • ▼
    DirectorExecutivesNeogenomics Inc
    64,952 USD11SEC
    2,300 shares@ US$28.240.2% of flowCommon StockSEC:0001077183-20-000045:2
  • ▼
    DirectorExecutivesNeogenomics Inc
    564,800 USD11SEC
    20,000 shares@ US$28.241.3% of flowCommon StockSEC:0001077183-20-000045:3
  • ◇
    DirectorExecutivesNeogenomics Inc
    478,000 USD11SEC
    100,000 shares@ US$4.780.9% of flowCommon StockSEC:0001077183-20-000003:0

25 of 90 declarations